Rajdhan Tissues Profile
Key Indicators
- Authorised Capital ₹ 2.70 M
- Paid Up Capital ₹ 2.61 M
- Company Age 14 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.50 M
- Satisfied Charges ₹ 1.00 Cr
- Revenue Growth -9.83%
- Profit Growth -10.99%
- Ebitda -55.04%
- Net Worth 11.11%
- Total Assets -4.14%
About Rajdhan Tissues
Rajdhan Tissues Private Limited (RTPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 October 2010 and has a history of 14 years and three months. Its registered office is in Ludhiana, Punjab, India.
The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.70 M and a paid-up capital of Rs 2.61 M.
The company currently has active open charges totaling ₹7.50 M. The company has closed loans amounting to ₹1.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sonia and Tarvinder Kumar serve as directors at the Company.
Company Details
- Location
Ludhiana, Punjab, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U74900PB2010PTC034367
- Company No.
034367
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Oct 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Rajdhan Tissues?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sonia  | Whole-Time Director | 18-Oct-2010 | Current |
| Tarvinder Kumar | Whole-Time Director | 30-Jul-2021 | Current |
Financial Performance of Rajdhan Tissues.
Rajdhan Tissues Private Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 9.83% decrease. The company also saw a substantial fall in profitability, with a 10.99% decrease in profit. The company's net worth Soared by an impressive increase of 11.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rajdhan Tissues?
In 2021, Rajdhan Tissues had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹7.50 M
₹10.00 M
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.75 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 May 2014 | Hdfc Bank Limited | ₹7.50 M | Open |
| 02 Jun 2011 | Oriental Bank Of Commerce | ₹6.50 M | Satisfied |
| 02 Jun 2011 | Oriental Bank Of Commerce | ₹3.50 M | Satisfied |
How Many Employees Work at Rajdhan Tissues?
Unlock and access historical data on people associated with Rajdhan Tissues, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rajdhan Tissues, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rajdhan Tissues's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
